Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Clearmind Medicine

Tracked across 4 events · 37 articles · First seen Jun 18, 2026 · Last active Sep 11, 2026

Sentiment
44
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Clearmind Medicine received two U.S. patents, strengthening its intellectual property portfolio for binge behavior regulators and advancing its clinical programs for related disorders. This enhances the company's market position and potential for commercialization.
Jun 18, 2026 · 7 articles
2 70
Business
Impact: Clearmind is the sponsor of the trial and the primary beneficiary of the DSMB approval, which advances its lead candidate CMND-100 into patient testing and supports its clinical development program.
Aug 06, 2026 · 6 articles
2 10
Business
Impact: Clearmind Medicine is the acquirer, paying $2.5 million for a 51% stake and providing a $1.5 million loan. This diversification into EV charging technology may be viewed positively, though it is a small deal relative to its biotech focus.
Sep 04, 2026 · 8 articles
2 25
Tech
Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biopharmaceutical company developing non-hallucinogenic psychedelic-derived neuroplastogens, announced the initiation of Phase IIa, the next stage of its double-blind, placebo-controlled Phase I/IIa clinical trial evaluating CMND-100 for the treatment…
Impact: Clearmind Medicine is the sponsor and central actor of the event, advancing its lead candidate CMND-100 into Phase IIa and enrolling the first AUD patients. The clinical progress is a positive milestone that could support investor sentiment and the company's Nasdaq-listed shares.
Sep 01, 2026 · 16 articles
85 Clearmind Medicine initiated Phase IIa trialClearmind CMND-100 Phase...
70 Clearmind Medicine reported positive safety resultsClearmind CMND-100 Phase...
ERGEN INTELLIGENCE
Track Clearmind Medicine live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.